ABBOTT has reported double digit
earnings per share (EPS) growth for
the 2012 third quarter.
According to Abbott its third-quarter
ongoing EPS is US$1.30, a
year-on-year increase of 10.2%.
The period also saw the company
clock a worldwide sales increase of
4.1%.
Abbott CEO Miles White also said
that the company now is “on track
to split into two separate leading
healthcare companies in Jan 2013”.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Oct 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Oct 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.